Brooks Lab Peer Comparison

NSE: BROOKS | BSE: 533543

₹59.18

₹-2.35 (-3.82%)

As on 21-Sep-2026 15:04IST

Market cap

₹177 Cr

Revenue (TTM)

₹83 Cr

P/E Ratio

13.4

P/B Ratio

1.4

Div. Yield

0 %

Edit

	Brooks Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Market cap (₹ Cr)	177	21,050	20,743	18,010	18,432
Revenue (₹ Cr)	83	2,287	1,682	3,230	2,570
Net Profit (₹ Cr)	4.57	678.07	273.51	666.92	735.15
Net Margin (%)	5.42	28.10	16.19	20.60	26.88
RoE (%)	11.09	19.73	11.15	18.75	19.16
Price to Earnings	13.41	31.64	69.77	27.97	25.07
Price-To-Book	1.43	5.73	7.72	4.47	4.18

Income Statement (₹ Cr)

	Brooks Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Operating Revenue	83.19	2,287.33	1,682.47	3,229.67	2,569.77
Total Income	84.32	2,413.29	1,689.83	3,237.12	2,735.39
Total Expenditure	77.39	1,490.75	1,203.91	2,090.06	1,628.14
EBITDA	5.80	796.58	478.55	1,139.61	941.63
Depreciation	1.61	78.10	126.01	281.06	57.58
EBIT	4.18	718.48	352.55	858.55	884.05
Interest	0.74	0.88	52.11	190.64	7.69
Other Income	1.13	125.96	7.37	7.45	165.62
Exceptional Items	0.00	0.00	12.16	-17.24	-49.16
Profit before Tax	4.57	843.56	319.96	658.12	992.82
Provision for Tax	0.00	165.49	46.45	-8.80	257.67
Profit after Tax	4.57	678.07	273.51	666.92	735.15

	Brooks Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Shareholder's Funds	122.66	3,586.42	2,591.20	3,902.67	4,202.90
Minority Interest	0.00	-12.71	0.00	-21.81	0.00
Non-Current Liabilities	3.70	28.74	266.35	1,392.75	91.50
Current Liabilities	21.81	385.94	848.06	2,077.10	627.48
Total Liabilities	148.17	4,037.51	3,705.61	7,246.72	4,921.88

	Brooks Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Non-Current Assets	106.94	1,291.22	2,525.44	5,617.77	770.28
Current Assets	37.42	2,585.66	1,109.77	1,539.85	3,803.22
Total Assets	148.17	4,037.51	3,705.61	7,246.72	4,921.88
Total Debt*	7.28	0.57	657.97	2,309.68	2.50
Net Current Assets	15.60	2,199.72	261.71	-537.25	3,175.74
Contingent Liabilities	122.94	17.53	160.01	51.57	370.49

	Brooks Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Cash From Operating Activities	9.29	523.24	342.18	537.99	967.57
Cash Flow from Investing Activities	-2.92	-582.30	-325.92	-369.46	-561.67
Cash from Financing Activities	0.17	-46.46	13.62	-313.53	-798.31
Net Cash Inflow / Outflow	6.54	-105.52	29.88	-145.00	-392.41

	Brooks Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
ROCE (%)	21.72	24.97	11.43	14.47	23.39
ROE (%)	11.09	19.73	11.15	18.75	19.16
ROA (%)	3.36	18.69	7.80	9.26	14.95
EBIT Margin (%)	5.03	31.41	20.95	26.58	34.40
Net Margin (%)	5.42	28.10	16.19	20.60	26.88
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Brooks Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Revenue Growth (%)	-7.71	15.01	27.91	9.59	10.69
EBIT Growth (%)	-32.07	18.45	58.32	16.84	24.14
Net Profit Growth (%)	-22.20	19.61	149.56	62.68	-9.09
EPS Growth (%)	927.88	17.73	-3.57	67.41	14.40
Book Value Growth (%)	25.03	26.75	9.67	36.71	-0.34

	Brooks Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Price / Earnings	13.69	31.39	71.24	27.75	23.73
Price / Book Value	1.46	5.69	7.43	4.54	4.15
Dividend Yield (%)	0.00	0.29	0.06	0.00	1.87
EV/EBITDA	31.15	24.96	43.00	18.03	16.14
Market Cap (₹ Cr)	110.43	11,439.22	6,819.66	17,980.08	21,592.90

	Brooks Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debt to Equity	0.01	0.00	0.07	0.24	0.00
Short term debt to equity ratio	0.05	0.00	0.16	0.12	0.00
Current Ratio	1.72	6.70	1.31	0.74	6.06
Quick Ratio	1.21	5.59	0.88	0.53	5.31
Interest Coverage	7.19	959.59	7.14	4.45	130.11

	Brooks Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debtors to sales (%)	19.37	36.10	30.84	21.07	7.07
Asset Turnover	0.61	0.63	0.48	0.45	0.52
Receivable days	76.86	121.68	113.81	63.88	26.06
Inventory Days	43.05	63.83	84.76	43.27	65.95
Payable days	89.64	108.28	101.94	151.85	81.01
Cash Conversion Cycle	30.27	77.23	96.62	-44.70	11.00

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.